Unlocking the Value of Closed Loop Marketing Analytics to Drive Customer Centricity

Posted by Saby Mitra on Thu, Jul 10, 2014

A significant portion of closed loop marketing (CLM) programs in the pharmaceutical industry have traditionally focused on converting paper assets to digital content and pushing this digital content to the sales representative’s tablet as detailing aids.


>
Read More

To Score with Customers, Aim for Yardage Not Touchdowns

Posted by Pratap Khedkar on Thu, Jun 26, 2014

Pharmaceutical and biotechnology companies are beginning to take a more customer-centric view of their operations—standing in customers’ shoes and interacting with them the way customers want, not just delivering a product.


>
Read More

The Secret Ingredient for Successful Social Listening

Posted by Jackie Cuyvers on Thu, May 29, 2014

Do you ever wonder if there is a secret ingredient for social-listening success? Given the huge volume of conversation online—is there a way to definitively separate the signal from the noise? How do you get relevant conversations that lead to actionable insights—not just conversations and data? It all boils down to one thing: asking the right question.


>
Read More

The Artful Science (and Scientific Art) of Social Listening

Posted by Jackie Cuyvers on Wed, May 14, 2014

The uninitiated may believe “social-media listening” or “social listening” is a tool-based insight machine, delivering answers like coins from a winning slot machine. That’s far from accurate. When you begin social listening, monitoring with a tool or platform is only the first step. Listening is more proactive—and allows for a deeper understanding, leading the individual to gain insight.


>
Read More

Blockbuster Drug Boycott? What ESI’s Sovaldi Threat Means to Big Pharma

Posted by Bill Coyle on Wed, Apr 23, 2014

Pharmacy benefit manager Express Scripts (ESI) recently threatened to form a coalition of customers and network members that would drop coverage of Gilead’s much-heralded, yet costly hepatitis C drug Sovaldi once viable competition arises. ESI’s announcement sparked conversations throughout the U.S. pharma industry, especially among companies coming to market with specialty drugs in the next one to two years, namely:


>
Read More